Enzyme Replacement Therapy Market Size - By Enzyme (Alglucosidase alfa, Agalsidase beta, Imiglucerase), Indication (Gaucher, MPS, Pompe, SCID, Fabry), Route of Administration, End-user, Global Forecast 2023-2032

Enzyme Replacement Therapy Market Size - By Enzyme (Alglucosidase alfa, Agalsidase beta, Imiglucerase), Indication (Gaucher, MPS, Pompe, SCID, Fabry), Route of Administration, End-user, Global Forecast 2023-2032


Enzyme Replacement Therapy Market size is set to exhibit over 7% CAGR from 2023 to 2032, driven by the broader acceptance of biologics and standard treatments for various genetic disorders.

Biologics, including enzyme replacement therapy (ERT) are gaining prominence as advanced and targeted treatments for genetic disorders, such as Gaucher disease and Fabry disease. The therapeutic efficacy and specificity of biologics and the subsequently rising adoption amongst patients and healthcare providers will also boost the market growth. For instance, in November 2023, Takeda's ADZYNMA received clearance from the U.S. FDA as the first and only recombinant ADAMTS13 enzyme replacement medication for the treatment of congenital thrombotic thrombocytopenic purpura (cTTP).

The enzyme replacement therapy industry is segmented into enzyme type, indication, route of administration, end-user, and region.

With respect to enzyme type, the market value from imiglucerase segment is anticipated to attain 8.4% CAGR from 2023-2032. Imiglucerase has emerged as an effective enzyme replacement therapy for the treatment of Gaucher disease. The expanding patient pool coupled with the rising awareness and diagnosis of rare diseases is amplifying the demand for Imiglucerase-based ERTs. Moreover, the rising advancements in biotechnology and continuous research will contribute to the segment growth.

Based on end-user, the ERT industry from the infusion centers segment is likely to record 7.5% CAGR through 2032. The rising prevalence of enzyme deficiency disorders coupled with the increasing acceptance of enzyme replacement therapies is adding significantly to the demand for infusion center services. Additionally, the increasing patient preference for infusion centers due to the availability of convenient and controlled environment for the treatment is likely to support the segment growth.

Regionally, the Europe enzyme replacement therapy market size is slated to observe 6.8% CAGR through 2032 driven advanced healthcare infrastructure, increasing awareness, and the rising prevalence of enzyme deficiency disorders. Moreover, collaborations between pharmaceutical companies and research institutions in Europe will contribute to increasing advancements in ERT technologies. Additionally, the growing commitment to improving patient outcomes through innovative therapies will augment the regional industry outlook. For instance, in May 2023, the European Commission granted marketing authorization for pegunigalsidase alfa, the Poly (ethylene glycol) (PEG) ylated enzyme for Fabry disease.


Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Enzyme replacement therapy 360 degree synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Region trends
2.1.3 Enzyme type trends
2.1.4 Indication trends
2.1.5 Route of Administration trends
2.1.6 End-user trends
Chapter 3 Enzyme Replacement Therapy Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of rare genetic disorders
3.2.1.2 Rising demand for effective treatment options
3.2.1.3 Growing awareness of rare genetic diseases
3.2.1.4 Advancements in biotechnology and genetic engineering
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of therapy
3.2.2.2 Limited availability of ERT products
3.3 Growth potential analysis
3.3.1 By enzyme type
3.3.2 By indication
3.3.3 By route of administration
3.3.4 By end-user
3.3.5 By region
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Technology landscape
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic dashboard, 2022
Chapter 5 Enzyme Replacement Therapy Market Estimates and Forecast, By Enzyme Type, 2018-2032 (USD Million)
5.1 Key trends, by enzyme type
5.2 Imiglucerase
5.3 Agalsidase beta
5.4 Taliglucerase
5.5 Velaglucerase alfa
5.6 Laronidase
5.7 Alglucosidase alfa
5.8 Galsulfase
5.9 Idursulfase
5.10 Pancreatic enzymes
5.11 Pegademase
5.12 Other enzyme types
Chapter 6 Enzyme Replacement Therapy Market Estimates and Forecast, By Indication, 2018-2032 (USD Million)
6.1 Key trends, by indication
6.2 Gaucher disease
6.3 Fabry disease
6.4 Pompe disease
6.5 Plasma cell disorders
6.6 SCID
6.7 Mucopolysaccharidosis (MPS)
6.7.1 MPS I - Hurler, Hurler Scheie and Scheie
6.7.2 MPS II - Hunter
6.7.3 MPS III - Sanfilippo
6.7.4 Other mucopolysaccharidosis
6.8 Other indications
Chapter 7 Enzyme Replacement Therapy Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)
7.1 Key trends, by route of administration
7.2 Parenteral
7.3 Oral
Chapter 8 Enzyme Replacement Therapy Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)
8.1 Key trends, by end-user
8.2 Hospitals
8.3 Infusion centers
8.4 Other end-users
Chapter 9 Enzyme Replacement Therapy Market Estimates and Forecast, By Region, 2018-2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Sanofi
10.2 Biomarin Pharmaceutical Inc.
10.3 AbbVie Inc.
10.4 Pfizer, Inc.
10.5 Alexion Pharmaceuticals Inc.
10.6 Allergan plc
10.7 Horizon Pharma Public Limited Company
10.8 Recordati Rare Diseases
10.9 Protalix Biotherapeutics
10.10 Amicus Therapeutics, Inc.
Data Tables
TABLE 1 Product mapping
TABLE 2 Market revenue, by enzyme type (2022)
TABLE 3 Market revenue, by indication (2022)
TABLE 4 Market revenue, by route of administration (2022)
TABLE 5 Market revenue, by end-user (2022)
TABLE 6 Market share, by region (2022)
TABLE 7 Global enzyme replacement therapy market size, by region, 2018 - 2022 (USD Million)
TABLE 8 Global enzyme replacement therapy market size, by region, 2018 - 2022 (USD Million)
TABLE 9 Global enzyme replacement therapy market size, by enzyme type, 2018 - 2022 (USD Million)
TABLE 10 Global enzyme replacement therapy market size, by enzyme type, 2018 - 2022 (USD Million)
TABLE 11 Global enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 12 Global enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 13 Global enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 14 Global enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 15 Global enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 16 Global enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 17 Industry impact forces
TABLE 18 Imiglucerase market size, 2018-2022 (USD Million)
TABLE 19 Imiglucerase market size, 2023-2032 (USD Million)
TABLE 20 Agalsidase beta market size, 2018-2022 (USD Million)
TABLE 21 Agalsidase beta market size, 2023-2032 (USD Million)
TABLE 22 Taliglucerase market size, 2018-2022 (USD Million)
TABLE 23 Taliglucerase market size, 2023-2032 (USD Million)
TABLE 24 Velaglucerase alfa market size, 2018-2022 (USD Million)
TABLE 25 Velaglucerase alfa market size, 2023-2032 (USD Million)
TABLE 26 Laronidase market size, 2018-2022 (USD Million)
TABLE 27 Laronidase market size, 2023-2032 (USD Million)
TABLE 28 Alglucosidase alfa market size, 2018-2022 (USD Million)
TABLE 29 Alglucosidase alfa market size, 2023-2032 (USD Million)
TABLE 30 Galsulfase market size, 2018-2022 (USD Million)
TABLE 31 Galsulfase market size, 2023-2032 (USD Million)
TABLE 32 Idursulfase market size, 2018-2022 (USD Million)
TABLE 33 Idursulfase market size, 2023-2032 (USD Million)
TABLE 34 Pancreatic enzymes market size, 2018-2022 (USD Million)
TABLE 35 Pancreatic enzymes market size, 2023-2032 (USD Million)
TABLE 36 Pegademase market size, 2018-2022 (USD Million)
TABLE 37 Pegademase market size, 2023-2032 (USD Million)
TABLE 38 Other enzyme types market size, 2018-2022 (USD Million)
TABLE 39 Other enzyme types market size, 2023-2032 (USD Million)
TABLE 40 Gaucher disease market size, 2018-2022 (USD Million)
TABLE 41 Gaucher disease market size, 2023-2032 (USD Million)
TABLE 42 Fabry disease market size, 2018-2022 (USD Million)
TABLE 43 Fabry disease market size, 2023-2032 (USD Million)
TABLE 44 Pompe disease market size, 2018-2022 (USD Million)
TABLE 45 Pompe disease market size, 2023-2032 (USD Million)
TABLE 46 SCID market size, 2018-2022 (USD Million)
TABLE 47 SCID market size, 2023-2032 (USD Million)
TABLE 48 Mucopolysaccharidosis (MPS) market size, 2018-2022 (USD Million)
TABLE 49 Mucopolysaccharidosis (MPS) market size, 2023-2032 (USD Million)
TABLE 50 MPS I - Hurler, Hurler Scheie and Scheie market size, 2018-2022 (USD Million)
TABLE 51 MPS I - Hurler, Hurler Scheie and Scheie market size, 2023-2032 (USD Million)
TABLE 52 MPS II - Hunter market size, 2018-2022 (USD Million)
TABLE 53 MPS II - Hunter market size, 2023-2032 (USD Million)
TABLE 54 MPS III - Sanfilippo market size, 2018-2022 (USD Million)
TABLE 55 MPS III - Sanfilippo market size, 2023-2032 (USD Million)
TABLE 56 Other mucopolysaccharidosis market size, 2018-2022 (USD Million)
TABLE 57 Other mucopolysaccharidosis market size, 2023-2032 (USD Million)
TABLE 58 Other indications market size, 2018-2022 (USD Million)
TABLE 59 Other indications market size, 2023-2032 (USD Million)
TABLE 60 Parenteral market size, 2018-2022 (USD Million)
TABLE 61 Parenteral market size, 2023-2032 (USD Million)
TABLE 62 Oral market size, 2018-2022 (USD Million)
TABLE 63 Oral market size, 2023-2032 (USD Million)
TABLE 64 Hospitals market size, 2018-2022 (USD Million)
TABLE 65 Hospitals market size, 2023-2032 (USD Million)
TABLE 66 Infusion centers market size, 2018-2022 (USD Million)
TABLE 67 Infusion centers market size, 2023-2032 (USD Million)
TABLE 68 Other end-users market size, 2018-2022 (USD Million)
TABLE 69 Other end-users market size, 2023-2032 (USD Million)
TABLE 70 North America enzyme replacement therapy Market size, by country, 2018-2022 (USD Million)
TABLE 71 North America enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
TABLE 72 North America enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 73 North America enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 74 North America enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 75 North America enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 76 North America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 77 North America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 78 North America enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 79 North America enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 80 North America enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 81 North America enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 82 U.S. enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 83 U.S. enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 84 U.S. enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 85 U.S. enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 86 U.S. enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 87 U.S. enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 88 U.S. enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 89 U.S. enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 90 U.S. enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 91 U.S. enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 92 Canada enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 93 Canada enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 94 Canada enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 95 Canada enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 96 Canada enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 97 Canada enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 98 Canada enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 99 Canada enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 100 Canada enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 101 Canada enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 102 Europe enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
TABLE 103 Europe enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
TABLE 104 Europe enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 105 Europe enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 106 Europe enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 107 Europe enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 108 Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 109 Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 110 Europe enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 111 Europe enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 112 Europe enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 113 Europe enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 114 Germany enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 115 Germany enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 116 Germany enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 117 Germany enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 118 Germany enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 119 Germany enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 120 Germany enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 121 Germany enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 122 Germany enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 123 Germany enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 124 UK enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 125 UK enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 126 UK enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 127 UK enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 128 UK enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 129 UK enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 130 UK enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 131 UK enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 132 UK enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 133 UK enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 134 France enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 135 France enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 136 France enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 137 France enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 138 France enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 139 France enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 140 France enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 141 France enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 142 France enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 143 France enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 144 Spain enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 145 Spain enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 146 Spain enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 147 Spain enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 148 Spain enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 149 Spain enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 150 Spain enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 151 Spain enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 152 Spain enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 153 Spain enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 154 Italy enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 155 Italy enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 156 Italy enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 157 Italy enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 158 Italy enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 159 Italy enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 160 Italy enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 161 Italy enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 162 Italy enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 163 Italy enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 164 Rest of Europe enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 165 Rest of Europe enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 166 Rest of Europe enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 167 Rest of Europe enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 168 Rest of Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 169 Rest of Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 170 Rest of Europe enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 171 Rest of Europe enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 172 Rest of Europe enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 173 Rest of Europe enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 174 Asia Pacific enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
TABLE 175 Asia Pacific enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
TABLE 176 Asia Pacific enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 177 Asia Pacific enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 178 Asia Pacific enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 179 Asia Pacific enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 180 Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 181 Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 182 Asia Pacific enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 183 Asia Pacific enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 184 Asia Pacific enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 185 Asia Pacific enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 186 Japan enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 187 Japan enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 188 Japan enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 189 Japan enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 190 Japan enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 191 Japan enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 192 Japan enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 193 Japan enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 194 Japan enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 195 Japan enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 196 China enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 197 China enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 198 China enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 199 China enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 200 China enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 201 China enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 202 China enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 203 China enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 204 China enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 205 China enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 206 India enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 207 India enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 208 India enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 209 India enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 210 India enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 211 India enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 212 India enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 213 India enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 214 India enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 215 India enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 216 Australia enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 217 Australia enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 218 Australia enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 219 Australia enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 220 Australia enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 221 Australia enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 222 Australia enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 223 Australia enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 224 Australia enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 225 Australia enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 226 South Korea enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 227 South Korea enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 228 South Korea enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 229 South Korea enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 230 South Korea enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 231 South Korea enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 232 South Korea enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 233 South Korea enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 234 South Korea enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 235 South Korea enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 236 Rest of Asia Pacific enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 237 Rest of Asia Pacific enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 238 Rest of Asia Pacific enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 239 Rest of Asia Pacific enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 240 Rest of Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 241 Rest of Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 242 Rest of Asia Pacific enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 243 Rest of Asia Pacific enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 244 Rest of Asia Pacific enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 245 Rest of Asia Pacific enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 246 Latin America enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
TABLE 247 Latin America enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
TABLE 248 Latin America enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 249 Latin America enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 250 Latin America enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 251 Latin America enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 252 Latin America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 253 Latin America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 254 Latin America enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 255 Latin America enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 256 Latin America enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 257 Latin America enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 258 Brazil enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 259 Brazil enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 260 Brazil enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 261 Brazil enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 262 Brazil enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 263 Brazil enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 264 Brazil enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 265 Brazil enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 266 Brazil enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 267 Brazil enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
TABLE 268 Mexico enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
TABLE 269 Mexico enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
TABLE 270 Mexico enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
TABLE 271 Mexico enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
TABLE 272 Mexico enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
TABLE 273 Mexico enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
TABLE 274 Mexico enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
TABLE 275 Mexico enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
TABLE 276 Mexico enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
TABLE 277 Mexico enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings